Login with your work email address to view charts. No credit card required.
| Art Unit: | 1612 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 504 — Plant protecting and regulating compositions 514 — Drug, bio-affecting and body treating compositions 510 — Cleaning compositions for solid surfaces, auxiliary compositions therefor, or processes of preparing the compositions 623 — Prosthesis (i.e., artificial body members), parts thereof, or aids and accessories therefor 604 — Surgery |
| Phone: | Available with subscription |
| Email: | Available with subscription |
| Title: | Pat Examnr (Biology) |
| Service: | 4 years |
| Grade: | GS-09 |
| 3-Year Grant rate: | 59% over 51 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 72nd
|
With Examiner Tien, you have a 59% chance of getting an issued patent by 3 years after the first office action. Examiner Tien is a harder examiner and in the 72nd percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Tien, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Tien's grant rate is lower than that of Art Unit 1612 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Tien | 2.6 |
| Art Unit 1612 | 1.9 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.